SEC Filings

SEC Filings | Quarterly Earnings | Annual Reports
Form 10-Q
AVINGER INC filed this Form 10-Q on 08/09/2017
Document Outline
Entire Document (2809.8 KB)
Subdocument 1 - 10-Q - 10-Q
Page 1 - UNITED STATES
Page 2 - SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Page 3 - N/A
Page 4 - AVINGER, INC.
Page 5 - PART I. FINANCIAL INFORMATION
Page 6 - AVINGER, INC.
Page 7 - AVINGER, INC.
Page 8 - AVINGER, INC.
Page 9 - 2. Summary of Significant Accounting Policies
Page 10 - Revenue Recognition
Page 11 - Leases
Page 12 - Net Loss per Share
Page 13 - Recent Accounting Pronouncements
Page 14 - 4. Inventories
Page 15 - PDL BioPharma
Page 16 - 6. Capital Leases
Page 17 - Purchase Obligations
Page 18 - 8. Stockholders Equity (Deficit)
Page 19 - 2015 Employee Stock Purchase Plan
Page 20 - 10. Restructuring Charges and Expenses
Page 21 - ITEM 2.
Page 22 - Components of Our Results of Operations
Page 23 - Cost of Revenues and Gross Margin
Page 24 - Other Income (Expense), net
Page 25 - Restructuring.
Page 26 - Other Income (Expense), Net.
Page 27 - Cash Flows
Page 28 - Critical Accounting Policies and Estimates
Page 29 - Changes in Internal Control over Financial Reporting
Page 30 - Risks Related to Ownership of our Common Stock Our stock price may be volatile, and purchasers of ou
Page 31 - We have a significant amount of debt, which may affect our ability to operate our business and secur
Page 32 - Our limited commercialization experience and number of approved products makes it difficult to evalu
Page 33 - We rely heavily on our sales professionals to market and sell our products. If we are unable to hire
Page 34 - If our revenue does not improve, or if our cost of revenue and/or operating expenses increase by a g
Page 35 - The expense and potential unavailability of insurance coverage for liabilities resulting from our pr
Page 36 - If our clinical trials are unsuccessful or significantly delayed, or if we do not complete our clini
Page 37 - From time to time, we engage outside parties to perform services related to certain of our clinical
Page 38 - Our ability to market our current products in the United States is limited to use in peripheral vess
Page 39 - If our manufacturing facility becomes damaged or inoperable, or we are required to vacate the facili
Page 40 - Our future growth depends on physician adoption of our Lumivascular platform products, which may req
Page 41 - Our ability to utilize our net operating loss carryforwards may be limited.
Page 42 - We are aware of patents held by third parties that may be asserted against us in litigation that cou
Page 43 - Risks Related to Government Regulation
Page 44 - Material modifications to our Lumivascular platform products may require new 510(k) clearances or pr
Page 45 - If we or our suppliers fail to comply with the FDA s QSR, our manufacturing operations could be dela
Page 46 - If we fail to comply with healthcare regulations, we could face substantial penalties and our busine
Page 47 - Compliance with environmental laws and regulations could be expensive. Failure to comply with enviro
Page 48 - Legal Proceedings
Page 49 - Sales of a substantial number of shares of our common stock in the public market, including by our e
Page 50 - We are an emerging growth company and we cannot be certain if the reduced disclosure requirements ap
Page 51 - Anti-takeover provisions in our amended and restated certificate of incorporation and bylaws and Del
Page 52 - Our amended and restated certificate of incorporation provides that the Court of Chancery of the Sta
Page 53 - SIGNATURES
Page 54 - EXHIBIT INDEX
Subdocument 2 - EX-31.1 - EX-31.1
Page 1 - Exhibit 31.1
Subdocument 3 - EX-31.2 - EX-31.2
Page 1 - Exhibit 31.2
Subdocument 4 - EX-32.1 - EX-32.1
Page 1 - Exhibit 32.1
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT (What's this?)
XBRL Viewer